A Chinese assets monitoring and management committee said on a social media website that a Chinese vaccine to prevent corona virus could be ready for sale soon or perhaps at the end of this year.

According to the commission on the Weechat website on May 29, a vaccine may appear on the market soon, possibly at the end of this year or early 2021.

The vaccines developed by the Wuhan and Beijing Biological Products Institutes have entered the second phase of clinical trials. The two institutes are affiliated with the government-made Sinopharm Medicines Group, which is administered by the Asset Control and Management Committee.

According to the commission, the production capacity of the Beijing Institute of Biological Products will be between 100 and 120 million doses annually.

China has five vaccines to prevent the emerging coronavirus in human trials. It was not possible to reach any of the institutes or the company for comment today, Saturday.